Guardian Pharmacy Services, Inc.
GRDN
$28.49
$0.220.78%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.33B | 1.28B | 1.23B | 1.17B | 1.12B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.33B | 1.28B | 1.23B | 1.17B | 1.12B |
| Cost of Revenue | 1.07B | 1.03B | 984.04M | 939.06M | 896.10M |
| Gross Profit | 260.48M | 253.62M | 244.37M | 231.85M | 223.16M |
| SG&A Expenses | 315.52M | 304.90M | 298.52M | 268.22M | 161.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.38B | 1.33B | 1.28B | 1.21B | 1.06B |
| Operating Income | -55.04M | -51.28M | -54.15M | -36.37M | 61.91M |
| Income Before Tax | -63.73M | -71.09M | -79.89M | -81.55M | 17.10M |
| Income Tax Expenses | 12.15M | 8.39M | 4.56M | 176.00K | -- |
| Earnings from Continuing Operations | -75.88 | -79.48 | -84.44 | -81.73 | 17.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -6.34M | -11.77M | -16.25M | -18.90M | -16.37M |
| Net Income | -82.22M | -91.25M | -100.70M | -100.62M | 728.00K |
| EBIT | -55.04M | -51.28M | -54.15M | -36.37M | 61.91M |
| EBITDA | -34.14M | -30.99M | -34.38M | -17.04M | 80.89M |
| EPS Basic | -1.50 | -1.65 | -1.80 | -2.00 | -- |
| Normalized Basic EPS | -0.69 | -0.75 | -0.89 | -1.10 | 0.10 |
| EPS Diluted | -1.51 | -1.66 | -1.81 | -2.00 | -- |
| Normalized Diluted EPS | -0.70 | -0.75 | -0.89 | -1.10 | 0.10 |
| Average Basic Shares Outstanding | 247.28M | 246.37M | 184.33M | 122.29M | 61.14M |
| Average Diluted Shares Outstanding | 249.98M | 247.92M | 185.01M | 122.29M | 61.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -14.97% | -31.69% | -35.80% | -45.77% | 5,532.14% |